James H Booth

Title: The Innovative Contributions of James H. Booth in Pharmaceutical Chemistry

Introduction

James H. Booth is a noteworthy inventor based in Montvale, NJ, known for his work in the field of pharmaceutical chemistry. With a solid understanding and expertise in drug development, he has made significant contributions that have advanced medical treatments.

Latest Patents

James H. Booth holds one patent for cephalosporanic acid derivatives, specifically the 7-acetamidocephalosporins. This patent reveals innovative compounds that are substituted at position 3 of the cephalosporin nucleus. The compounds include various groups where R2 is selected from hydrogen, amino, C1 to C6 alkylamino, and di-C1 to C6 alkylamino. Additionally, R3, R4, and R5 vary in their selection from hydrogen, hydroxy, C1 to C6 alkyl, C1 to C6 alkoxy, trifluoromethyl, substituted phenyl, and heterocyclic aryl. These advancements may contribute substantially to the field of antibiotics, showcasing Booth’s ingenuity.

Career Highlights

Throughout his career, James H. Booth has been associated with the American Cyanamid Company, a respected name in pharmaceutical research and development. His expertise and dedication to innovation have played a crucial role in furthering the company’s mission of delivering impactful healthcare solutions.

Collaborations

James H. Booth has worked alongside his coworker, Adma S. Ross, fostering a collaborative environment that emphasizes the importance of teamwork in innovative ventures. Such partnerships often lead to promising outcomes in research and development efforts.

Conclusion

James H. Booth's contributions to pharmaceutical chemistry, particularly through his patent on cephalosporanic acid derivatives, underline his position as an influential inventor. His work reflects a commitment to advancing medical science and improving treatment options, demonstrating the vital role of inventors in healthcare innovation.